Peritoneal Dialysis

1. Peritoneal Dialysis Julie Stinson Specialist Nurse, Renal Community Team University Hospitals of Leicester

2. Aims and Objectives To give an overview of Peritoneal Dialysis – how it works, therapy options To discuss the solutions used for PD To discuss the pharmacological considerations in PD

3. Peritoneal Dialysis Introduced late 1970’s Alternative treatment to Haemodialysis for End-stage Renal failure Home therapy, self-managed by patient Uses patients own natural membrane – the Peritoneum – for dialysis

4. What is Peritoneal Dialysis? • Peritoneal Dialysis (PD) utilises one of the bodies natural membranes • Fluid flows through a small plastic tube (catheter) into the peritoneal cavity • Whilst the fluid is inside the peritoneal cavity dialysis takes place • The fluid is changed every few hours, this is called an exchange Peritoneal cavity Catheter

5. The Peritoneal Cavity

6. How peritoneal dialysis works Removal of solutes by DIFFUSION Removal of fluid by OSMOSIS

7. 1 2 Bicarbonate Sodium Potassium Chloride Urea Creatinine Uric acid Peritoneal Dialysis Diffusion Movement of solutes from a strong solution to a weak solution across a semi - permeable membrane Blood Membrane Dialysate 1 - Red blood cell 2 - Bacteria Beta 2-m

8. Blood Dialysis Solution Water Solute Water Solute Peritoneal Dialysis Osmosis Movement of water from an area of low solute concentration to an area of high solute concentration.

9. Suitable patients Well motivated/ independent Diabetic Elderly Patients with residual renal function Needle phobic patients Patients with cardiac disease Have adequate storage space for fluids/ equipment

10. Contraindications for PD Chronic back pain COPD Diverticular disease Previous abdominal surgery Social circumstances -Lack of space at home for supplies Inability to self- manage treatment: physical or cognitive function

11. More advantages Less dietary restrictions Treatment of choice for diabetics No needles involved!

12. Catheter A flexible, silicone catheter is inserted into the Peritoneal cavity usually laproscopically (under local or general anaesthetic) Dacron cuffs secure in position in peritoneum Can be used after 2-4wks (post-operatively if necessary)

14. Types of Peritoneal Dialysis CAPD APD

15. What is CAPD? • CAPD stands for Continuous Ambulatory Peritoneal Dialysis • CAPD can be performed in any clean and convenient place • The manual exchanges use gravity to drain the used fluid out of the peritoneal cavity and replace it with fresh fluid • Most CAPD patients need to do 4 bag exchanges per day

16. CAPD Continuous Ambulatory Peritoneal Dialysis Dialysis takes place whilst patient continues normal daily activities Performed manually (usually) 4 times every day 1.5 – 2.5 litres of fluid per exchange Each exchange takes 30-40 minutes

17. Automated Peritoneal Dialysis Dialysis is performed by an automated machine and exchanges are done at night while patient sleeps Machine has 3 main functions: Heats PD fluid to body temperature Controls time of exchange and amount of fluid used Monitors treatment (safety alarms)

18. APD Automated Peritoneal Dialysis Performed every night Free from exchanges during the day Greater flexibility in volume and time of exchanges Can be performed by a carer so possible for for patients unable to self manage

19. Types of PD fluids • Primarily made up of glucose as this provides the osmotic gradient required to remove water • Other constituents include • Lactate/bicarbonate as a buffer • Electrolytes i.e. sodium, calcium, etc • Amino Acids/bicarbonate • Varies from 1.5L to 3Litres

20. Types of PD Fluids Glucose Icodextrin - Extraneal Amino acids - Nutrineal Bicarbonate - Physioneal (Baxter Healthcare)

21. Glucose Traditional PD fluids are glucose based and use Lactate as buffer - Bioincompatible Glucose (as osmotic agent) in different concentrations: 1.36%, 2.27% 3.86% More glucose = more fluid removal High concentrations of glucose – 1.36% bag = 75mmol/litre, 3.86% = 215mmol/l

22. Constant exposure to glucose can damage Peritoneum in time Absorption of glucose leads to hyperglycaemia in Diabetics, insulin resistance, obesity

23. Extraneal Glucose polymer, starch based fluid – 7.5% Icodextrin Allows better ultrafiltration Used once daily for longer dwell time (at least 8 hours) Reduces glucose load, so maintains better glycaemic control for diabetics; reduces weight gain

24. Nutrineal 1.1% Amino acid – 87mmol/litre One bag per day – at mealtime exchange in CAPD, with o/night mix in APD Absorption rate 70-80% amino acids, hence can use in malnourished pts

25. Physioneal Uses Bicarbonate + Lactate as buffer – Biocompatible Prolongs efficiency of peritoneum as dialysis membrane

26. PHARMACOLOGICAL CONSIDERATIONS IN PD

27. Complications of PD (with Pharmacy involvement) Peritonitis Exit site and Tunnel infection Constipation Mechanical

28. Treatment protocols given are specific to University Hospitals of Leicester Most PD units will have variations in protocols! – Please refer to your local policies

29. Constipation Constipation can lead to PD catheter problems- fluid will not drain out/in Important to take regular laxatives Usually Lactulose and Senna Some patients may need Sodium Docusate Picolax if severe constipation

30. Blocked catheter caused by Fibrin May require UROKINASE lock Urokinase 5000u in 5mls Saline - for 2 hour dwell into catheter

31. PD Peritonitis Inflammation of peritoneum usually due to infection Signs and symptoms: Cloudy PD fluid +/- abdominal pain, ?fever, nausea, D and V Diagnosis based on symptoms of cloudy fluid, pain Fluid will show > 100 white cells; Identification of organisms on Gram stain or subsequent culture of fluid

32. Treatment of peritonitis Outpatient ‘APD regime’ Gram positive - Bolus IP Vancomycin – 1-2gram dependant on body weight Gram negative - oral Ciprofloxacin (500mg bd) No organism – both Vanc and Cipro Day 4 – vanc level checked; <15mg/ml=further dose: Repeat at days 8 and 12

33. Inpatients regime Gram positive organisms - • IP Vancomycin 25mg/litre for 10days Gram negative – IP Gentamycin 5mg/litre No growth – give both

34. Special considerations for Pseudomonas, fungal Pseudomonas - IP Gentamycin 7.5mg/l alternate bags + Oral Ciprofloxacin 750mg bd Continued for 4 weeks (weekly Gent levels)? Tube removed if recurrent, non-resolving peritonitis Fungal – Tube removal (Ref: UHL Policy – PD peritonitis diagnosis and treatment)

35. Recurrent peritonitis: • Rifampicin 600mg once day for 4 weeks • (weekly LFTs) + Urokinase flush 5000u/5mls on day 4 and 7/8

36. Exit Site and Tunnel infections Exit site Commonly caused by skin commensals Clinical signs of infection:- swab taken; Instigate abx treatment- Flucloxacillin 500mg qds x 5days (as appropriate) /Erythromicin 500mgs qds if Penicillin sensitive Gram positive organism -continue 7 days Gram negative – Ciprofloxacin 500mg bd x7days )

37. If pt is Staph Aureus carrier, treated with nasal and topical Mupiricin (Swab each clinic visit (ref: UHL policy: PD catheter ESI)

38. Tunnel infection • Cause usually unresolved ESI. • Inflammed tract under skin along tube tunnel= erythema, tenderness • Treated with IV Vancomycin 1g; likely admission • Tube removal if unresolved (r/v 48hrs)

39. THANK YOU!